Search
for
Sort by
Research 511–540 of 1000+
- Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Deucravacitinib in dermatology: current indication and existing off-label data
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real-world evidence in alopecia areata treatment: A narrative review
- A review of Janus kinase inhibitor use in scarring alopecia
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Review of Promising Off-Label Use of Deucravacitinib
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- An ERK-dependent molecular switch antagonizes fibrosis and promotes regeneration in spiny mice ( <i>Acomys</i> )
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Citrullination at the Inflammatory Skin Barrier
- Resident Memory T Cells in Autoimmune Skin Diseases
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Janus kinase inhibitors for alopecia areata: A narrative review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors